When someone has a heart attack, lowering body temperature can prevent brain damage, so can cooling the brain itself.
RhinoChill brain freeze allows first responders in emergency situations to improve survivability in their patients by applying a chilling nose spray to cool the brain on site.
BeneChill created the RhinoChill device based on technology that has been developed over the past decade. The San Diego company has run clinical trials and is hoping to start selling the device in Europe this summer. FDA approval will take about two years.